Clinical Trials Coordination Group (CTCG) plenary meeting (HMA working group) and Pediatric Committee (PDCO) Meeting

The CTCG is composed of representatives from each EU/EEA National Competent Authority (NCA) for the authorisation and surveillance of clinical trials with medicinal products for human use. The CTCG is an active partner in initiatives such as ACT-EU and collaborates with other groups within the European Medicines Regulatory Network (EMRN) and the European Commission. The Paediatric Committee (PDCO) was established under Regulation (EC) 1901/2006, with the primary aim of promoting the development of medicines suitable for children, ensuring their safety and efficacy for paediatric use.